EDAP
EDAP TMSBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
EDAP has real primary-source support for a growth story: 2025 HIFU revenue rose 39%, system placements grew 69%, U.S. procedures grew 28% in Q4, and management reiterated 2026 HIFU growth guidance of 34%-45% [#PR-2026-03-25].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
EIB financing improves liquidity but adds warrant dilution.
Momentum
96
Value
42
Sentiment
34
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.60 · Bull $5.50 · Bear $2.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-05-28 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $6.84
Why
Momentum96 · Δ7d -
Value42 · Δ7d -0.0
Sentiment34 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
96
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
42
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
34
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 96.1 / Value 42.4 / Sentiment 33.5
Fundamentals (TTM)As of 2026-05-28
Fundamentals (TTM)
As of 2026-05-28
Market Cap
$157.42M
Beta
-0.16
Shares Out
37.39M
P/E (TTM) · Derived
-6.0
P/S (TTM)
1.78
P/FCF (TTM)
-
Rev YoY
+6.0%
EPS YoY
+22.1%
Gross Margin
+43.2%
Op Margin
-32.0%
Net Debt
-$19.96M
Current Ratio
1.41
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology